Monologue: OpenAI's Non-Profit Problem

In this week's monologue, Ed Zitron walks you through the precarious nature of OpenAI's non-profit status - and how a petition to the California Attorney general is an existential threat to the company. Petition: https://aboutblaw.com/bhNa --- LINKS: https://www.tinyurl.com/betterofflinelinks Newsletter: https://www.wheresyoured.at/ Reddit: https://www.reddit.com/r/BetterOffline/ Discord: chat.wheresyoured.at https://discord.com/invite/QUUQUP9szv Ed's Socials: https://twitter.com/edzitron https://www.instagram.com/edzitron https://bsky.app/profile/edzitron.com https://www.threads.net/@edzitron See omnystudio.com/listener https://omnystudio.com/listener for privacy information.

Speaker names marked ? are inferred from speaking time and the show’s known hosts — they are not voice-verified.

• 0:00Speaker 00

  This is an iHeart Podcast. Guaranteed Human.

• 0:05Speaker 01

  Wait, I came in for two things. How is this $47? All right, we're gonna need a plan here.

• 0:13Speaker 02

  Just start simple with Bank of America Advantage Safe Balance Banking. No overdraft item fees, no monthly maintenance fee if you're under 25.

• 0:21Speaker 01

  Oh, that's actually really simple.

• 0:24Speaker 02

  Safe Balance Banking, one less thing to figure out. Learn more at bofa.com/simplbanking. Terms and conditions apply. Bank of America and a member FDIC.

• 0:39Ed Zitron?

  Hi, I'm Ed Zitron, and this is your weekly Better Offline monologue.

• 0:50Ed Zitron?

  Precarious. That's the nature of the generative AI industry, and especially OpenAI, a company that has never made a profit, has no pathway to profitability, and is contingent upon other companies spending tens of billions of dollars on new infrastructure to power their models in the future. Throughout countless podcasts and newsletters, I've argued that all of these factors mean that OpenAI, and by extension, the greater generative AI industry, will eventually collapse. OpenAI is just one of a long line of dominos, and it really only takes one to fall before the entire thing collapses. But by comparison, I haven't really paid nearly as much of the attention as I should have to the unusual structure of OpenAI, which I believe will also contribute to its downfall. OpenAI was initially started as a nonprofit intended to further the safe development of artificial intelligence,

• 1:36Ed Zitron?

  if you believe them. Over time, it morphed into an entirely different beast, becoming the most valuable startup in history, and the startup that has now raised the most capital in history, sort of. But for legal reasons, it couldn't quite walk away from its nonprofit origins. And so we're now left with this strange hybrid that consists of a nonprofit that owns much of OpenAI's intellectual property and assets, and a for-profit business sort of tacked on awkwardly at the side. In order to satiate its infinite thirst for capital, OpenAI must radically restructure the entire organisation, moving valuable assets and intellectual property from the non-profit to the for-profit entity. Their ability to raise money is entirely contingent upon this, as generally investors don't plough tens of billions of dollars into philanthropic ventures where they will

• 2:21Ed Zitron?

  never see a return. Indeed, many of OpenAI's previous funding rounds have had caveats that would radically alter the terms of their deal if OpenAI fails to convert into a for-profit business. Last October, they raised $6.6 billion from a bevy of investors, but the deal included a covenant of sorts, that should they fail to convert into a for-profit entity in two years, so October 2026, the investment would convert into a loan. OpenAI would in effect have to return the capital to investors and potentially pay a punishing interest rate. Similarly, OpenAI's latest $40 billion with SoftBank is structured in a way where $10 billion of the dollars are contingent on OpenAI becoming a for-profit business. The point I'm trying to make is that for OpenAI, this current structure represents

• 3:06Ed Zitron?

  an existential threat. In many ways, it is more dire than any shortage of compute capacity, or the fact that they spend billions of dollars more than they'll ever make. So they just change structure, right? What's the big deal? Well, this is a complex and bureaucratic procedure that typically only happens in sectors like healthcare, where hospitals are bought out by larger for-profit companies. I struggle to think of any similar examples in tech, and even if those examples exist, they don't involve entities of the size and value of OpenAI, or indeed the prominence. The transformation isn't something that Sam Altman can do unilaterally either. In essence, he needs the consent of regulators and lawmakers in the state of California. We've already seen OpenAI's moves be challenged by the likes of Elon Musk and Mark Zuckerberg,

• 3:50Ed Zitron?

  although these efforts did not or have yet to amount to much, though there is an upcoming trial with Elon Musk over this. Part of the complexity comes from the very nature of what it means to be a nonprofit. Nonprofits enjoy certain tax benefits, both from their exemption, from taxation, to the benefits that come when a person makes a charitable donation to a nonprofit. If you give money to like the Red Cross or a church or whatever, you can write that off against your taxes. As a result, OpenAI is constrained by what it can do with the assets that are held within the nonprofit. Those assets are supposed to be used for the benefit of society, to serve some kind of charitable purpose. OpenAI can't just transfer them to a for-profit entity. Doesn't work like that, nor should it. Even though they're very much trying to make it.

• 4:34Ed Zitron?

  Now, a link to this in the episode notes, but a recent petition against OpenAI's restructuring alleges that OpenAI has already effectively broken the rules against how nonprofits should operate and manage their assets, with the first violation coming in 2019, right at the start of OpenAI's metamorphosis and around the time when it obtained its first billion dollars' worth of investment from Microsoft. Addressed to the Attorney General of California and signed by innumerable figures in California and national philanthropy, it articulates a compelling case that OpenAI has already broken the law in several meaningful ways and urges the state to take action to prevent a further dilution of the OpenAI charitable mission. It describes these violations as, and I quote, "factually complex but legally simple."

• 5:15Ed Zitron?

  It claims that the 2019 restructuring, which created the for-profit element, involved the wrongful transfer of assets from the nonprofit. This is bad in and of itself, but as time dragged on the influence and relevance of the nonprofit wing over the for-profit entity, it effectively ended. It gives the example of the November 2023 coup, when Sam Altman was fired from the company over alleged dishonesty about the safety processes surrounding model development, and also a bunch of other stuff like not telling the board that ChatGPT was coming out. Anyway, this firing, the letter states, came at the behest of the nonprofit directors. As we all know, it didn't take Sam Altman long to return to the helm of OpenAI in the same role that he'd left. Many of the board members that had approved his termination left, and though they signed

• 5:57Ed Zitron?

  a letter, it was very much a "they have me, my family" kind of thing, or I should say, "they have my stock units." And they were replaced by those who were more aligned for the for-profit goals of OpenAI. The petition also makes the case that OpenAI's renunciation of its commitment to open-source research within its purpose clause, the thing that defines what a nonprofit is for, also represented an illegal diversion of assets. Open-source software benefits whoever uses it, whereas proprietary software, even if it's provided for free, has comparatively fewer benefits to society. You can't change or modify or improve a program and you're at the best... you're really at the... whatever the vendor wants to do as far as accessing or using the platform or program or whatever it might do. In practice, there's little open about OpenAI.

• 6:42Ed Zitron?

  They share little source code and don't even provide specifics about the training data they use. They're less concerned with public research and now shrouds their development in the same cloak of secrecy that you would expect from basically any other tech company. Now, they're claiming they're gonna release an open-weighted model, but it's bullshit. I'm sorry, that's not enough. Now, the letter does make some specific demands. It wants the AG to investigate what assets were siphoned off from the nonprofit, block any conversion until the investigation is completed, and make sure that all charitable assets are returned to the nonprofit and indeed to create a truly independent entity, separate from Sam Altman and the business interests of OpenAI, to act as a steward for these assets. If this petition succeeded in delaying the conversion, OpenAI's future becomes much

• 7:26Ed Zitron?

  more uncertain and perhaps may not even be possible. It'll make it harder to raise new funds, that'll only increase their cash burn, as OpenAI will now be forced to start making repayments and investments that were automatically converted into loans. Will it succeed? Maybe. First, this petition doesn't come from a rival with an axe to grind against Sam Altman like Elon Musk. The Black Freedom Fund, the Asian Law Caucus, and the California Teamsters Public Affairs Council aren't exactly the natural adversaries of Altman. Unless they, of course, secretly hate people who wear Patagonia vests, in which case I retract the entire last sentence and also add that I heartily congratulate them and agree with them. Moreover, this petition isn't framed about tech or AI or AI safety, but rather something far more simple. It's about what a nonprofit is and how it should be run.

• 8:11Ed Zitron?

  And if, as the letter's authors argue, OpenAI should be allowed to restructure without being challenged or scrutinized, it will set a dangerous precedent that would make it harder to protect the charitable mission of nonprofits and make them easier for them to be plundered, like I'd argue OpenAI has. It's a strong case, and while it's hard to tell if the Attorney General will take it on, it could lay the groundwork for OpenAI's demise. And I'm sure some of you would love that. Oh no, I might too.

• 8:44Speaker 04

  Empower is all about helping you invest well, so you can go out and live a little. And their Free Empower Personal Dashboard shows you your full financial life in one place. You'll be able to see your net worth, monitor budgets, analyze your portfolio, set retirement goals, and more. Whether you're saving for something big, want to treat yourself, friends, or family, or meet long-term goals, Empower helps you see where you stand. You've worked hard for your money, and Empower can help you make the most of it. Download the Empower Personal Dashboard or visit empower.com. Not an Empower client paid or sponsored.

• 9:16Speaker 01

  Wait, I came in for two things. How is this $47? Alright, we're gonna need a plan here.

• 9:24Speaker 02

  Just start simple, with Bank of America Advantage Safe Balance Banking. No overdraft agam fees, no monthly maintenance fee if you're under 25.

• 9:32Speaker 01

  Oh, that's actually really simple.

• 9:35Speaker 02

  Safe Balance Banking, one less thing to figure out. Learn more at bofa.com/simplebanking. Terms and conditions apply. Bank of America and a member FDIC.

• 9:45Speaker 05

  She's been thinking about this sleepover all week, but I think about her food allergies all the time. Fortunately, her doctor prescribes Zolair, omalizumab. It's proven to significantly reduce allergic reactions if a food allergy accident happens.

• 9:58Speaker 06

  Zolir 150mg is a prescription medication used to treat food allergy in people one year of age and older to reduce allergic reactions due to accidental exposure to one or more foods. While taking Zolir, you should continue to avoid all foods to which you are allergic. Don't use if you are allergic to Zolir. Zolir may cause a severe, life-threatening allergic reaction called anaphylaxis. Tell your doctor if you ever had anaphylaxis. Get help right away if you have trouble breathing or if you have swelling of your throat or tongue. Zolir should not be used for the emergency treatment of allergic reactions, including anaphylaxis. Zolir is for maintenance use to reduce allergic reactions, including anaphylaxis, while avoiding food allergens. Serious side effects such as cancer, fever, muscle aches and rash, parasitic infection, or heart and circulation problems have been reported. Please see zolir.com for full prescribing information. Ask an allergist about Zolir.

• 10:41Speaker 06

  This is an advertisement for Zolir paid for by Genentech and Novartis.

• 10:45Speaker 07

  Snoring, gasping for air during sleep, daytime sleepiness? I'm Shaquille O'Neal and this shouldn't be anybody's experience. Ask your doctor about Zepbound Trzepatide, the first and only FDA-approved prescription medicine for moderate to severe obstructive sleep apnea in adults with obesity. Zepbound is a prescription medicine used with a reduced-calorie diet and increased physical activity to help adults with moderate to severe obstructive sleep apnea, OSA, and obesity to improve their OSA. Zepbound is approved as a 2.5, 5, 7.5, 10, 12.5, or 15-milligram injection. Zepbound contains Trzepatide and should not be used with other Trzepatide-containing products or any GLP-1 receptor agonist medicines. It is not known if Zepbound is safe and effective for use in children.

• 11:29Speaker 07

  Don't share needles or pens, or reuse needles. Don't take if allergic to it, or if you or someone in your family had medullary thyroid cancer, or if you've had multiple endocrine neoplasia syndrome type 2. Tell your doctor if you get a lump or swelling in your neck. Stop Zepbound and call your doctor if you have severe stomach pain or a serious allergic reaction. Severe side effects may include inflamed pancreas or gallbladder problems. Tell your doctor if you experience vision changes before scheduled procedures with anesthesia, if you're nursing, pregnant, plant-to-be, or taking birth control pills. Taking Zepbound with a sulfonylurea or insulin may cause low blood sugar. Side effects include nausea, diarrhea, and vomiting, which can cause dehydration and worsen kidney problems. Talk to your doctor. Call 1-800-545-5979,

• 12:13Speaker 07

  or visit zepbound.lily.com.

• 12:16Speaker 00

  This is an iHeart Podcast. Guaranteed Human.